Skip to main content

Latest stock market podcasts

From the helm: Starpharma’s (ASX:SPL) Chief Executive Officer, Dr. Jackie Fairley

Grady Wulff
November 8, 2022
In this instalment of our From the helm series, Bell Direct’s Grady Wulff speaks to Starpharma’s (ASX:SPL) Chief Executive Officer, Dr. Jackie Fairley.
Starpharma Holdings Limited (ASX:SPL) is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers. In this video Dr. Fairley discusses:
  • (0:56) A brief overview of Starpharma
  • (2:31) Growing distribution network for Viraleze
  • (3:29) SPL’s exciting oncology portfolio and key partnerships with major companies
  • (4:56) How Viraleze works and the market opportunity going forward
  • (6:09) What’s coming up next for SPL

Weekly Wrap 6 June

Bell Direct
June 6, 2025

Morning Bell 5 June

Bell Direct
June 5, 2025

Morning Bell 4 June

Bell Direct
June 4, 2025

Morning Bell 3 June

Bell Direct
June 3, 2025

Morning Bell 2 June

Bell Direct
June 2, 2025

Weekly Wrap 30 May

Bell Direct
May 30, 2025

Morning Bell 29 May

Bell Direct
May 29, 2025

Morning Bell 28 May

Grady Wulff
May 28, 2025

Morning Bell 27 May

Bell Direct
May 27, 2025

Morning Bell 26 May

Bell Direct
May 26, 2025